DE FERRARI, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 6.631
AS - Asia 5.591
EU - Europa 3.575
SA - Sud America 1.121
AF - Africa 192
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.123
Nazione #
US - Stati Uniti d'America 6.440
CN - Cina 2.841
SG - Singapore 1.120
IE - Irlanda 1.030
BR - Brasile 858
VN - Vietnam 620
HK - Hong Kong 467
RU - Federazione Russa 454
DE - Germania 432
IT - Italia 362
FI - Finlandia 358
UA - Ucraina 234
FR - Francia 231
GB - Regno Unito 158
IN - India 128
CA - Canada 116
SE - Svezia 111
AR - Argentina 106
ZA - Sudafrica 95
BD - Bangladesh 66
AT - Austria 61
ID - Indonesia 48
MX - Messico 48
IQ - Iraq 46
EC - Ecuador 44
PK - Pakistan 41
JP - Giappone 39
CO - Colombia 35
PL - Polonia 29
VE - Venezuela 26
PY - Paraguay 23
NL - Olanda 22
TR - Turchia 22
BE - Belgio 21
MY - Malesia 21
MA - Marocco 19
ES - Italia 18
SA - Arabia Saudita 18
KE - Kenya 17
UZ - Uzbekistan 15
CL - Cile 13
EG - Egitto 13
PH - Filippine 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
JO - Giordania 9
AL - Albania 8
AZ - Azerbaigian 8
AU - Australia 7
IL - Israele 6
PE - Perù 6
TH - Thailandia 6
UY - Uruguay 6
BG - Bulgaria 5
CR - Costa Rica 5
JM - Giamaica 5
KZ - Kazakistan 5
MU - Mauritius 5
PT - Portogallo 5
RO - Romania 5
AO - Angola 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LT - Lituania 4
NP - Nepal 4
PS - Palestinian Territory 4
QA - Qatar 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
IR - Iran 3
KR - Corea 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
SR - Suriname 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BO - Bolivia 1
Totale 17.104
Città #
Dublin 1.028
Chandler 746
Nanjing 655
Ashburn 633
San Jose 630
Jacksonville 596
Dallas 543
Singapore 539
Hong Kong 455
Beijing 429
Nanchang 261
Boardman 247
Ho Chi Minh City 220
Princeton 206
Lawrence 198
Medford 190
Changsha 186
Lauterbourg 177
Shenyang 174
Wilmington 173
Helsinki 162
Los Angeles 156
Hebei 155
Hanoi 154
Jiaxing 145
New York 124
Munich 121
Hangzhou 112
Tianjin 106
Moscow 89
Buffalo 87
Council Bluffs 86
São Paulo 82
Pavia 79
Ann Arbor 77
Johannesburg 73
Redondo Beach 72
Shanghai 59
Nuremberg 54
Mcallen 52
Milan 46
Orem 43
Santa Clara 38
Montréal 37
Norwalk 37
Tokyo 36
Dearborn 33
Fairfield 33
Woodbridge 33
Frankfurt am Main 30
Rio de Janeiro 28
Vienna 28
Atlanta 27
Guangzhou 27
Warsaw 27
Turku 25
Haiphong 24
Seattle 23
Chennai 21
Brooklyn 20
Chicago 20
Da Nang 20
Montreal 20
Ottawa 20
Toronto 20
Biên Hòa 19
Curitiba 19
Baghdad 18
San Francisco 18
Verona 18
Brasília 17
Brussels 17
Jinan 17
Joinville 17
Stockholm 16
Mexico City 15
Quito 15
Zhengzhou 15
Des Moines 14
Guayaquil 14
Jakarta 14
Pune 14
Redwood City 14
Tashkent 14
Buenos Aires 13
Mumbai 13
Denver 12
Manchester 12
Nairobi 12
New Delhi 12
Phoenix 12
Rome 12
Boston 11
Dhaka 11
Falkenstein 11
Kunming 11
Lahore 11
Poplar 11
Asunción 10
Belo Horizonte 10
Totale 11.536
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 251
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 250
Amiodarone 173
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 168
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes 164
A challenging case of permanent junctional reciprocating tachycardia (pjrt) in post-partum cardiogenic shock 147
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 145
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 143
Gene symbol: KCNH2 140
Atrial arrhythmias prevalence in heart transplant patients. 134
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 133
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 128
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 128
Past and future of the "Pavia eCPR program" 127
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 126
[Vagus nerve stimulation for the treatment of heart failure] 126
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial 125
Amiodarone in the treatment of Atrial Fibrillation: New Perspectives from Clinical Trials 124
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 121
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 121
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 120
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Previous Myocardial Infarction 119
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 119
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 118
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 115
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 114
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction 113
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 113
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 113
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 112
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 112
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 112
Successful repair of lateral wall pseudoaneurysm via left anterior minithoracotomy using port-access tecnique 109
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 109
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 109
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 109
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 108
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 108
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 106
Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. 106
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 106
Autonomic nervous system and arrhythmias. 105
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 105
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 104
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. 103
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER. 101
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis 100
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 100
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 99
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 99
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 99
End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest 99
Leptin affects the inflammatory response after STEMI 99
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 97
Arterial baroreflexes and ventricular tachycardia. 97
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 97
Effects of Intra-Aortic Balloon Pump on Markers of Right Ventricular Dysfunction Among End-Stage Heart Failure Patients Candidates to Cardiac Transplant or Ventricular Assist Device 96
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 96
Autonomic reflexes and ventricular tachycardia. 94
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 94
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 93
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 93
Extracorporeal membrane oxigenation support decreases mortality in acute myocardial infarction complicated by refractory cardiogenic shock 92
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 92
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 91
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 90
Gene symbol: SCN5A 90
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems 90
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study 90
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 90
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. 89
Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. 88
Gene symbol: KCNH2 88
Calmodulin mutations associated with recurrent cardiac arrest in infants. 88
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy 87
Protective effect of vagal hyperactivity on reperfusion arrhythmias 87
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial 86
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 85
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. 85
Letter by Ferrari et al regarding article, "long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction" 84
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 84
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. 83
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 83
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 83
Prevalence and features of incessant atrial arrhythmias after heart transplantation with standard technique. 82
Two-to-one AV block associated with the congenital long QT syndrome. 82
Use of extracorporeal membrane oxygenation in primary refractory cardiac shock and cardiac arrest; a single centre experience 82
Prevalenza della aritmie atriali nei pazienti sottoposti a trapianto cardiaco ortotopico secondo la tecnica di Lower e Shumway 82
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 81
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy 81
The ALPHA study (T-wave alternans in patients with heart failure): rationale, design and endpoints. 81
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 80
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. 79
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. 78
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 78
Vagal activity and ventricular fibrillation 78
Le cicatrici degli interventi chirurgici di compartimentalizzazione atriale possono condurre a distanza dalla procedura? 78
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. 77
Current challenges for clinical trials of cardiovascular medical devices 77
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. 76
Totale 10.591
Categoria #
all - tutte 75.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022791 10 1 14 14 5 27 9 51 46 16 121 477
2022/20232.402 306 164 22 153 197 216 2 105 1.154 15 48 20
2023/2024898 54 258 24 56 62 248 34 59 6 32 41 24
2024/20252.288 56 236 57 54 37 72 107 151 629 75 242 572
2025/20266.774 479 618 1.007 1.019 748 271 1.068 263 502 456 235 108
Totale 17.442